PA
PFE icon

PSI Advisors’s Pfizer PFE Stock Holding History

PSI Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Sell
13,564
-641
-5% -$16.8K 0.08% 113
2026
Q1 		$399K Buy
14,205
+400
+3% +$10.6K 0.1% 103
2025
Q4 		$344K Sell
13,805
-7,500
-35% -$189K 0.09% 95
2025
Q3 		$543K Buy
21,305
+100
+0.5% +$2.47K 0.14% 74
2025
Q2 		$514K Sell
21,205
-1,759
-8% -$41K 0.25% 54
2025
Q1 		$582K Sell
22,964
-4,859
-17% -$127K 0.19% 64
2024
Q4 		$738K Buy
27,823
+297
+1% +$8.06K 0.22% 62
2024
Q3 		$796K Sell
27,526
-309
-1% -$9.01K 0.23% 66
2024
Q2 		$779K Buy
27,835
+200
+0.7% +$5.51K 0.25% 60
2024
Q1 		$767K Sell
27,635
-1,873
-6% -$52K 0.28% 59
2023
Q4 		$850K Buy
29,508
+4,729
+19% +$143K 0.32% 58
2023
Q3 		$822K Buy
24,779
+3,680
+17% +$130K 0.36% 51
2023
Q2 		$774K Buy
21,099
+2,090
+11% +$81.3K 0.34% 57
2023
Q1 		$776K Buy
19,009
+5,322
+39% +$230K 0.37% 52
2022
Q4 		$701K Sell
13,687
-1,551
-10% -$74.4K 0.37% 52
2022
Q3 		$667K Buy
15,238
+767
+5% +$37.3K 0.35% 57
2022
Q2 		$758K Buy
14,471
+538
+4% +$27.4K 0.37% 59
2022
Q1 		$721K Sell
13,933
-193
-1% -$10K 0.3% 72
2021
Q4 		$834K Sell
14,126
-4,968
-26% -$246K 0.34% 60
2021
Q3 		$822K Sell
19,094
-9,640
-34% -$427K 0.38% 57
2021
Q2 		$1.13M Sell
28,734
-731
-2% -$28.4K 0.59% 38
2021
Q1 		$1.07M Buy
29,465
+5,774
+24% +$205K 0.63% 39
2020
Q4 		$872K Sell
23,691
-1,241
-5% -$45.5K 0.6% 36
2020
Q3 		$868K Buy
24,932
+1,233
+5% +$43.2K 0.66% 34
2020
Q2 		$735K Buy
23,699
+415
+2% +$14.1K 0.59% 39
2020
Q1 		$721K Sell
23,284
-9,218
-28% -$314K 0.66% 33
2019
Q4 		$1.21M Buy
+32,502
New +$1.16M 0.78% 24

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PSI Advisors's PFE Position: Q2 2026 in Review

PSI Advisors reduced its Pfizer (PFE) stake by 4.5% in Q2 2026, selling an estimated $16.8K and leaving 13,564 shares worth $327K. The position accounts for 0.08% of the portfolio, ranked #113.

PSI Advisors first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.21M in Q4 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PSI Advisors held 13,564 shares of Pfizer worth $327K as of Q2 2026.
  • PSI Advisors sold 641 Pfizer shares in Q2 2026, an estimated $16.8K.
  • Pfizer made up 0.08% of PSI Advisors's portfolio in Q2 2026, its #113 holding.
  • PSI Advisors first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • PSI Advisors's Pfizer position peaked at $1.21M in Q4 2019.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PSI Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.